Compugen Ltd
NASDAQ:CGEN

Watchlist Manager
Compugen Ltd Logo
Compugen Ltd
NASDAQ:CGEN
Watchlist
Price: 1.43 USD 1.42% Market Closed
Market Cap: 133.8m USD
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one CGEN stock under the Base Case scenario is 1.02 USD. Compared to the current market price of 1.43 USD, Compugen Ltd is Overvalued by 29%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

CGEN Relative Value
Base Case
1.02 USD
Overvaluation 29%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

6
P/S
P/S
Price to Sales
6
vs History
63
vs Industry
36
Median 3Y
6.3
Median 5Y
8.1
Industry
4
Forward
19.2
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-4.1
Median 5Y
-9.4
Industry
30.6
Forward
-4.2
More Details
Negative
P/OCF
P/OCF
Price to OCF
N/A
vs History
vs Industry
50
Median 3Y
-2.2
Median 5Y
-5.4
Industry
20.8
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
34
Median 3Y
-2.1
Median 5Y
-5.4
Industry
35.5
More Details
2.7
P/B
P/B
Price to Book Value
2.7
vs History
53
vs Industry
40
Median 3Y
2.3
Median 5Y
2.8
Industry
2.8
More Details
1.8
EV/S
EV/S
Enterprise Value to Sales
1.8
vs History
57
vs Industry
73
Median 3Y
1.7
Median 5Y
2.5
Industry
3.9
Forward
5.7
More Details
2.9
EV/GP
EV/GP
Enterprise Value to Gross Profit
2.9
vs History
28
vs Industry
80
Median 3Y
0.8
Median 5Y
-2
Industry
8.9
More Details
Negative
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
N/A
vs History
vs Industry
54
Median 3Y
-1.2
Median 5Y
-4.8
Industry
17.7
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
50
Median 3Y
-1.2
Median 5Y
-4.6
Industry
23.3
Forward
-1.1
More Details
Negative
EV/OCF
EV/OCF
Enterprise Value to OCF
N/A
vs History
vs Industry
53
Median 3Y
-0.1
Median 5Y
-2.3
Industry
19.6
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
40
Median 3Y
-0.1
Median 5Y
-2.3
Industry
25.9
More Details
3.7
EV/IC
EV/IC
Enterprise Value to IC
3.7
vs History
74
vs Industry
23
Median 3Y
6.9
Median 5Y
36.6
Industry
2.5
More Details

Multiples Across Competitors

CGEN Competitors Multiples
Compugen Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
IL
Compugen Ltd
NASDAQ:CGEN
133.8m USD 6 -6.9 -2.1 -2
US
PerkinElmer Inc
LSE:0KHE
966.6B USD 345.4 3 389.4 1 192.1 2 423.4
US
Thermo Fisher Scientific Inc
NYSE:TMO
182.1B USD 4.2 27.8 21.2 26.6
US
Danaher Corp
NYSE:DHR
143.8B USD 6 42.1 22.1 33.2
KR
Samsung Biologics Co Ltd
KRX:207940
71.2T KRW 14.1 55.3 31.1 43.5
CH
Lonza Group AG
SIX:LONN
39.7B CHF 5.6 54.1 39.4 39.4
CN
WuXi AppTec Co Ltd
SSE:603259
318.5B CNY 7.4 23.1 25 25
US
Agilent Technologies Inc
NYSE:A
35.3B USD 5.3 30.5 20.5 24.1
US
IQVIA Holdings Inc
NYSE:IQV
31.1B USD 2 25.3 12.7 19.1
US
Mettler-Toledo International Inc
NYSE:MTD
26.5B USD 6.8 31.8 23.2 25.8
FR
Sartorius Stedim Biotech SA
PAR:DIM
17B EUR 5.9 75.4 25.9 44.8
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
IL
Compugen Ltd
NASDAQ:CGEN
Average EV/EBITDA: 141.3
Negative Multiple: -2.1 		N/A N/A
US
P
PerkinElmer Inc
LSE:0KHE
1 192.1
6%
198.7
US
Thermo Fisher Scientific Inc
NYSE:TMO
21.2
5%
4.2
US
Danaher Corp
NYSE:DHR
22.1
7%
3.2
KR
Samsung Biologics Co Ltd
KRX:207940
31.1
17%
1.8
CH
Lonza Group AG
SIX:LONN
39.4
18%
2.2
CN
WuXi AppTec Co Ltd
SSE:603259
25
24%
1
US
Agilent Technologies Inc
NYSE:A
20.5
10%
2
US
IQVIA Holdings Inc
NYSE:IQV
12.7
8%
1.6
US
Mettler-Toledo International Inc
NYSE:MTD
23.2
4%
5.8
FR
Sartorius Stedim Biotech SA
PAR:DIM
25.9
20%
1.3

See Also

Summary
CGEN intrinsic value, competitors valuation, and company profile.
DCF Valuation
CGEN stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CGEN stock valuation using valuation multiples.
Wall Street Estimates
CGEN price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CGEN stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 279,600+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.